Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
Tuesday 07 May 2024 5:21 pm

Truspine chief resigns ‘with immediate effect’ amid investor efforts to oust him

By: Ben Lucas

Add as a preferred source on Google
Consultancy sector and AI
Ebury is in talks with Pollen Street about a potential takeover of Lumon

The chief executive of a London-listed medical technology firm has resigned following investor efforts to oust both him and the chief financial officer from the company. 

Truspine Technologies, which is looking to develop unique spinal medical devices, announced this morning that Laurence Strauss had resigned “with immediate effect” without giving further details. 

But Strauss told City PM that the decision was an “amicable” one. 

“I’ve no axe to grind against the company whatsoever,” he said, adding that the company will likely be looking for someone with greater industry experience to take the company forward. 

“It’s got to that stage where I felt that the input that I could give the company wasn’t necessarily going to be as effective going forward as it has been historically,” he said. 

Strauss said he was proud of the work he has done since he joined in March last year and was confident the company’s technologies will get approval from the US Food and Drug Administration “in the very near future”. 

“I’ve managed to take a company that was dead completely on its feet and turn it into a potential business,” he said. “I’ve achieved, I think, more than I was expected to achieve.”

His resignation comes after City PM recently reported that investors were continuing their battle to oust him and the firm’s chief financial officer, Norman Lott, in a bid to turn the company around. 

Read more

BP chair ousted over ‘volcanic’ behaviour after less than a year

Albert Manifold, former chair of BP, in a business suit at a corporate event, representing leadership transition news.

Investors have become increasingly frustrated as the company has failed to make any products since floating on London’s rival stock exchange Acquis in 2020 and it has repeatedly run into financial difficulties. 

But Strauss said that the decision was not linked to this campaign. 

“I don’t think it’s really a reaction to that,” he said. “Not one of my directors has turned around to me at any time and said, ‘you know, we’ve got these disgruntled shareholders who want you gone… do you think you ought to go?’ That’s never come [into] the discussion.”  

He did admit, however, he was “quite worn out from it all”. 

“It’s been a tough journey. When you take a company that’s mired in so much bad publicity with disgruntled shareholders, it takes it out of you,” he said. 

While Strauss said he will “be assisting for a smooth transition” he doesn’t intend to have any other proper role at the firm going forward. 

Geoff Miller, Truspine’s chairman, said in a statement: “I would like to thank Laurence for the work that he has done to progress the company’s development.” 

It is unclear when Truspine hopes to appoint a new chief executive. 

Read more

LivaNova to Present at Goldman Sachs Global Healthcare Conference in June

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

People & Organisations

  • Aquis
  • Shareholders
  • tech
  • Truspine Technologies

Related Topics

  • London business
  • Medicine

Trending Articles

  • Top Burnham adviser calls for capital gains and inheritance tax hikes

  • Housebuilding giants hit with £4.5bn lawsuit for allegedly overcharging buyers

  • Brewdog chief executive quits after only one year

  • A meeting with the breakfast king of Mayfair

  • As it happened: Stocks jump on defence and metals boost; Oil on track to shed a fifth on US-Iran peace hopes

More from City PM

  • BP chair ousted over ‘volcanic’ behaviour after less than a year

    Energy
    Albert Manifold, former chair of BP, in a business suit at a corporate event, representing leadership transition news.
  • LivaNova to Present at Goldman Sachs Global Healthcare Conference in June

    Business Wire
  • Jette Nygaard-Andersen Joins LivaNova Board as a New Director

    Business Wire
  • LivaNova Appoints Anne Liddy as Chief Legal Officer

    Business Wire
  • P&O Ferries to be probed over possible audit failings

    Accountancy
    PO Ferries vessel docked at port under a clear sky, showcasing maritime transport and travel industry operations.
  • KPMG Australia boss resigns amid whistleblower scandal

    Big Four
    KPMG hit with a new financial sanction
  • LivaNova Appoints Stefano Folli to Lead its Cardiopulmonary Business Unit

    Business Wire
  • Former Lloyd’s DEI leader left Beazley over non-financial misconduct allegations

    Insurance
    Beazley 2026 business forecast graph with financial data and growth trends displayed for February 24 analysis

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy